Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pelvic Neoplasms 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma 1Malignant Solid Neoplasm 1Lung Neoplasms 1Leiomyoma 1Colorectal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Chylous Ascites 1Carcinoma, Non-Small-Cell Lung 1Adenomyosis 1Abdominal Neoplasms 1

Interventions

Propofol 2Dexmedetomidine 2contrast agent BR1 1Therapeutics 1Surgical Procedures, Operative 1Sevoflurane 1Ropivacaine 1Paclitaxel 1Nitrous Oxide 1Metastasectomy 1Lidocaine 1Iohexol 1Imatinib Mesylate 1Glycopyrrolate 1Food, Formulated 1Fluorouracil 1FS 069 1Enoxaparin 1Embolization, Therapeutic 1Drug Therapy 1Doxorubicin 1Dietary Supplements 1Cytoreduction Surgical Procedures 1Continuous Positive Airway Pressure 1Cisplatin 1Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abdominal Neoplasms × Iohexol × Clear all
NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
42 enrolled
Gynecologic

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡